[1]李莹,刘沛红,危玲,等.多囊卵巢综合征患者孕前体质量指数对妊娠期 高血压疾病的影响[J].中国计划生育和妇产科,2020,(2):41-44,50.
 LI Ying,LIU Pei-hong,WEI Ling,et al.Effect of pre-pregnancy body mass index in patients with polycystic ovarian syndrome on hypertensive disorder complicating pregnancy[J].Chinese Journal of Family Planning & Gynecotokology,2020,(2):41-44,50.
点击复制

多囊卵巢综合征患者孕前体质量指数对妊娠期 高血压疾病的影响
分享到:

《中国计划生育和妇产科》[ISSN:1674-4020/CN:51-1708/R]

卷:
期数:
2020年2期
页码:
41-44,50
栏目:
论著与临床
出版日期:
2020-02-25

文章信息/Info

Title:
Effect of pre-pregnancy body mass index in patients with polycystic ovarian syndrome on hypertensive disorder complicating pregnancy
作者:
李莹1刘沛红2危玲1田宁1宋晶1陈奕1*
1100026北京,首都医科大学附属北京妇产医院产科;2251705山东滨州,惠民县人民医院内科
Author(s):
LI Ying1LIU Pei-hong2WEI Ling1TIAN Ning1SONG Jing1CHEN Yi1*
1.Department of Obstetrics and Gynecology,Beijing Obstetrics and Gynecology Hospital,Capital Medical University,Beijing 100026,P.R.China;2.Department of Internal Medicine, Huimin People's Hospital,Binzhou Shandong 251705,P.R.China
关键词:
多囊卵巢综合征体质量指数妊娠期高血压子痫前期
Keywords:
polycystic ovary syndrome body mass index pregnancy-induced hypertension preeclampsia
分类号:
R 71175
摘要:
目的探究多囊卵巢综合征(polycystic ovary syndrome, PCOS)患者孕前体质量指数(body mass index,BMI)与妊娠期高血压和子痫前期发病的相关性。方法回顾性分析2014~2017年在首都医科大学附属北京妇产医院建档并住院分娩的305例PCOS患者的临床资料,根据孕期BMI分为3组:正常组167例,超重组79例,肥胖组59例。比较3组患者一般情况、妊娠期高血压和子痫前期发病情况、分娩情况及新生儿结局,分析孕前BMI与妊娠期高血压和子痫前期发病的相关性。结果3组患者的年
Abstract:
ObjectiveTo explore the correlation between pre-pregnant body mass index (BMI) and pregnancy induced hypertension (PIH) and preeclampsia (PE) in patients with polycystic ovary syndrome (PCOS). MethodsRetrospective analysis of the clinical data of 305 PCOS

参考文献/References:

[1]Zhang Z, Xu H, Liu X, et al. Association of pregnancy-associated plasma protein A and vascular endothelial growth factor with pregnancy-induced hypertension [J]. Exp Ther Med,2019,18(3):1761-1767. [2]Kite C, Lahart I M, Afzal I, et al. Exercise, or exercise and diet for the management of polycystic ovary syndrome: a systematic review and meta-analysis [J]. Syst Rev,2019,8(1):51. [3]Masturzo B, Franze V, Germano C, et al. Risk of adverse pregnancy outcomes by pre-pregnancy body mass index among Italian population: a retrospective population-based cohort study on 27,807 deliveries [J]. Arch Gynecol Obstet,2019,299(4):983-991. [4]赵明,李光辉. 生活方式干预对妊娠期增重及妊娠结局的影响 [J]. 中华围产医学杂志,2014,17(8):508-511. [5]中华医学会妇产科学分会妊娠期高血压疾病学组. 妊娠期高血压疾病诊治指南(2015) [J]. 中华妇产科杂志,2015,50(10):721-728. [6]Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)[J]. Hum Reprod,2004,19(1):41-47. [7]李莹,伍绍文,陈奕. 妊娠期高血压疾病不良妊娠结局相关分析[J]. 中国计划生育和妇产科,2018,10(9):43-47, 54. [8]蒋红清,陈寒,宋慧颖,等. 妊娠期高血压疾病发病危险预测模型的建立分析[J]. 解放军医学院学报,2018,39(10):844-849. [9]Chen Z, Du J, Shao L, et al. Prepregnancy body mass index, gestational weight gain, and pregnancy outcomes in China [J]. Int J Gynaecol Obstet,2010,109(1):41-44. [10]王婷婷,付翰林,陈立章,等. 中国多囊卵巢综合征患者妊娠并发症发生率的Meta分析 [J]. 中南大学学报(医学版),2017,42(11):1300-1310. [11]Ye C, Ruan Y, Zou L, et al. The 2011 survey on hypertensive disorders of pregnancy (HDP) in China: prevalence, risk factors, complications, pregnancy and perinatal outcomes [J]. PLoS One,2014,9(6):e 100180. [12]Savitri A I, Zuithoff P, Browne J L, et al. Does pre-pregnancy BMI determine blood pressure during pregnancy? A prospective cohort study [J]. BMJ Open,2016,6(8):e 11626. [13]Roberts J M, Bodnar L M, Patrick T E, et al. The role of obesity in preeclampsia [J]. Pregnancy Hypertens,2011,1(1):6-16. [14]Masho S W, Urban P, Cha S, et al. Body mass index, weight gain, and hypertensive disorders in pregnancy [J]. Am J Hypertens,2016,29(6):763-771. [15]Taylor B D, Ness R B, Olsen J, et al. Serum leptin measured in early pregnancy is higher in women with preeclampsia compared with normotensive pregnant women [J]. Hypertension,2015,65(3):594-599. [16]Santos S, Voerman E, Amiano P, et al. Impact of maternal body mass index and gestational weight gain on pregnancy complications: an individual participant data meta-analysis of European, North American and Australian cohorts [J]. BJOG,2019,126(8):984-995. [17]Wang T, Fu H, Chen L, et al. Pregnancy complications among women with polycystic ovary syndrome in China: a Meta-analysis [J]. Zhong Nan Da Xue Xue Bao Yi Xue Ban,2017,42(11):1300-1310. [18]Lonnebotn M, Natvig G K, Benediktsdottir B, et al. Polycystic ovary syndrome, body mass index and hypertensive disorders in pregnancy [J]. Pregnancy Hypertens,2018,11:32-37. [19]Joham A E, Boyle J A, Zoungas S, et al. Hypertension in reproductive-aged women with polycystic ovary syndrome and association with obesity [J]. Am J Hypertens,2015,28(7):847-851. [20]Palomba S, De Wilde M A, Falbo A, et al. Pregnancy complications in women with polycystic ovary syndrome [J]. Hum Reprod Update,2015,21(5):575-592. [21]Boomsma C M, Eijkemans M J, Hughes E G, et al. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome [J]. Hum Reprod Update,2006,12(6):673-683. [22]Wu Y, Li P, Zhang D, et al. Metformin and pioglitazone combination therapy ameliorate polycystic ovary syndrome through AMPK/PI3K/JNK pathway [J]. Exp Ther Med,2018,15(2):2120-2127. [23]谢敏,马润玫. 多囊卵巢综合征高雄激素血症及胰岛素抵抗对产科并发症的影响 [J]. 实用妇产科杂志,2018,34(8):575-577.

相似文献/References:

[1]姜荣华,钟小英,潘萍,等.61例多囊卵巢综合征妇女行供精人工授精结局分析[J].中国计划生育和妇产科,2011,(04):0.
 JIANG Rong-hua,ZHONG Xiao-ying,PAN Ping.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(2):0.
[2]任涛,熊小英,蔡春芳,等.多囊卵巢综合征患者视黄醇结合蛋白-4的水平变化及意义[J].中国计划生育和妇产科,2013,(04):0.
 REN Tao *,XIONG Xiao-ying,CAI Chun-fang.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(2):0.
[3]龚衍,曾玖芝,李运星,等.不同剂量来曲唑对多囊卵巢综合征不孕症患者诱导排卵的临床观察[J].中国计划生育和妇产科,2013,(05):0.
 GONG Yan,ZENG Jiu-zhi,Li Yun-xing,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(2):0.
[4]李琳.无生育要求多囊卵巢综合征患者无排卵的处理[J].中国计划生育和妇产科,2014,(04):0.
 LI Lin,[J].Chinese Journal of Family Planning & Gynecotokology,2014,(2):0.
[5]刘振腾,郝翠芳.有生育要求的多囊卵巢综合征患者的治疗[J].中国计划生育和妇产科,2014,(04):0.
 LIU Zhen-teng,HAO Cui-fang,Reproductive Medical Center,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2014,(2):0.
[6]李淑红.腹腔镜下卵巢表面电凝术治疗多囊卵巢综合征的疗效分析[J].中国计划生育和妇产科,2014,(04):0.
 LI Shu-hong,[J].Chinese Journal of Family Planning & Gynecotokology,2014,(2):0.
[7]倪仁敏,杨冬梓.多囊卵巢综合征的发病概况[J].中国计划生育和妇产科,2014,(06):0.
[8]崔琳琳,陈子江.多囊卵巢综合征的临床诊断要点[J].中国计划生育和妇产科,2014,(06):0.
[9]刘义.多囊卵巢综合征长期管理与治疗策略[J].中国计划生育和妇产科,2014,(06):0.
[10]李尚为.多囊卵巢综合征的促排卵治疗[J].中国计划生育和妇产科,2014,(06):0.
[11]付蕾*,朱玉林,袁景川,等.多囊卵巢综合征患者的体质量指数对助孕妊娠结局的影响[J].中国计划生育和妇产科,2018,(6):60.
 FU Lei*,ZHU Yu-lin,YUAN Jing-chuan,et al.Effect of body mass index in patients with polycystic ovary syndrome on fertility pregnancy outcome[J].Chinese Journal of Family Planning & Gynecotokology,2018,(2):60.

备注/Memo

备注/Memo:
北京市优秀人才项目(项目编号:2016000021469G204);首都医科大学附属北京妇产医院中青年学科骨干培养专项(项目编号:fcyy201602)
更新日期/Last Update: 2020-02-25